Hairy polyp of the rhinopharynx – a rare and unrecognized entity

Autor: Dan Cristian GHEORGHE, Adina ZAMFIR-CHIRU-ANTON, LE ENE, AE STANCIU

Publikováno v: Romanian Journal of Medical Practice, Vol 15, Iss 1, Pp 112-114 (2020)

Hairy polyps are tumors that have been described in the literature as congenital masses usually found in the nasopharynx. Clinical symptoms are a consequence of disease dimensions and anatomical positioning. Although rare, this kind of tumors can be

Externí odkaz: https://doaj.org/article/3d18afe2af754e99ae0e83db52278303

Piriform sinus fistula management approach – our experience

Autor: Dan Cristian Gheorghe, Adina Zamfir-Chiru-Anton, AE Stanciu

Publikováno v: Romanian Medical Journal, Vol 67, Iss 1, Pp 99-101 (2020)

Branchial anomalies are a group of malformations resulting from incomplete closure of the pharyngeal pouches and clefts. They manifest as cysts, fistulae and sinus tracts located in the neck. We present the case of a 3 years-old girl admitted to the

Externí odkaz: https://doaj.org/article/5ee995ecf2794b9d8fa8ad3acd9db7d8

Eustachian Tube Teratoma: A Rare Entity.

Autor: Gheorghe DC; ENT Department, 'MarieCurie' Children Hospital, 'Carol Davila' University, Bucharest, Romania., Enculescu A; Pathology Department, 'Marie Curie' Children Hospital, Bucharest, Romania., Stanciu AE; Department of Carcinogenesis and Molecular Biology, Institute of Oncology Bucharest, Bucharest, Romania., Epure V; ENT Department, 'MarieCurie' Children Hospital, 'Carol Davila' University, Bucharest, Romania., Zamfir-Chiru-Anton A; ENT Department, 'Grigore Alexandrescu' Emergency Hospital for Children, Bucharest, Romania.

Publikováno v: Clinical pathology (Thousand Oaks, Ventura County, Calif.) [Clin Pathol] 2023 Aug 17; Vol. 16, pp. 2632010X231195231. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).

Correlation Studies between S100 Protein Level and Soluble MIA or Tissue MelanA and gp100 (HMB45) Expression in Cutaneous Melanoma.

Autor: Bolovan LM; Carcinogenesis and Molecular Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Ceausu M; Pathology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Stanciu AE; Carcinogenesis and Molecular Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Panait ME; Cancer Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Busca A; Cancer Biology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Hotnog CM; Center of Immunology, 'Stefan S. Nicolau' Institute of Virology, Romanian Academy, 030304 Bucharest, Romania., Bleotu C; Cellular and Molecular Pathology Department, 'Stefan S. Nicolau' Institute of Virology, Romanian Academy, 030304 Bucharest, Romania., Gales LN; Oncology Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Oncology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 252 Fundeni Ave, 022328 Bucharest, Romania., Georgescu MT; Oncology Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Oncology Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 252 Fundeni Ave, 022328 Bucharest, Romania., Prunoiu VM; Oncological Surgery Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Oncological Surgery Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania., Brasoveanu LI; Center of Immunology, 'Stefan S. Nicolau' Institute of Virology, Romanian Academy, 030304 Bucharest, Romania., Voinea SC; Oncological Surgery Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Oncological Surgery Department, Institute of Oncology 'Prof. Dr. Alexandru Trestioreanu', 022328 Bucharest, Romania.

Publikováno v: Journal of personalized medicine [J Pers Med] 2023 May 26; Vol. 13 (6). Date of Electronic Publication: 2023 May 26.

Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?

Autor: Gherghe M; Nuclear Medicine Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Nuclear Medicine Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Lazar AM; Nuclear Medicine Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Mutuleanu MD; Nuclear Medicine Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Nuclear Medicine Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Bordea CI; Surgical Oncology Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania.; Surgical Oncology Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Ionescu S; Surgical Oncology Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania.; General Surgery Department, University of Medicine and Pharmacy 'Carol Davila' Bucharest, 050474 Bucharest, Romania., Mihaila RI; Oncology Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Petroiu C; Nuclear Medicine Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania., Stanciu AE; Carcinogenesis and Molecular Biology Department, Institute of Oncology 'Professor Doctor Alexandru Trestioreanu', 022328 Bucharest, Romania.

Publikováno v: Cancers [Cancers (Basel)] 2022 Dec 29; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 29.